Capricor
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Capricor and other ETFs, options, and stocks.About CAPR
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps.
CAPR Key Statistics
CAPR News
Capricor Therapeutics, Inc. ((CAPR)) has held its Q4 earnings call. Read on for the main highlights of the call. Capricor Therapeutics, Inc. recently held its...
Capricor Therapeutics (CAPR) released expectation-beating results for the fourth quarter, sending the shares up over 5% in aftermarket trading. This comes on th...
Capricor Therapeutics, Inc. ( (CAPR) ) has released its Q4 earnings. Here is a breakdown of the information Capricor Therapeutics, Inc. presented to its investo...
Analyst ratings
100%
of 7 ratingsMore CAPR News
Capricor Therapeutics, Inc. ( ) shareholders won't be pleased to see that the share price has had a very rough month, dropping 27% and undoing the prior period'...
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Capricor Therapeutics (CAPR – Research Report) today and set a price target of $77.00. Jose...
Capricor Therapeutics (CAPR) announced long-term data from its ongoing HOPE-2 open label extension clinical trial, demonstrating the potential of the Company’s...